HB Wealth Management LLC grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 55.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,123 shares of the company's stock after buying an additional 2,193 shares during the quarter. HB Wealth Management LLC's holdings in HCA Healthcare were worth $2,116,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Sanders Capital LLC increased its stake in shares of HCA Healthcare by 1.0% in the fourth quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock valued at $3,498,417,000 after purchasing an additional 116,826 shares during the period. Geode Capital Management LLC grew its stake in shares of HCA Healthcare by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock worth $1,159,882,000 after purchasing an additional 50,321 shares during the last quarter. Capital World Investors lifted its position in shares of HCA Healthcare by 0.7% during the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company's stock valued at $878,975,000 after acquiring an additional 19,121 shares during the last quarter. Northern Trust Corp raised its stake in HCA Healthcare by 12.4% during the 4th quarter. Northern Trust Corp now owns 2,017,971 shares of the company's stock valued at $605,694,000 after purchasing an additional 223,248 shares during the period. Finally, Nuveen Asset Management LLC lifted its position in shares of HCA Healthcare by 4.5% in the fourth quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company's stock worth $560,011,000 after purchasing an additional 81,105 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.
HCA Healthcare Stock Up 0.6%
Shares of NYSE HCA traded up $2.28 during trading on Friday, hitting $356.27. The stock had a trading volume of 553,589 shares, compared to its average volume of 1,603,819. The company has a market capitalization of $85.71 billion, a PE ratio of 14.98, a PEG ratio of 1.12 and a beta of 1.47. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. The firm has a fifty day moving average of $371.06 and a two-hundred day moving average of $346.78. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the firm posted $5.50 EPS. The business's revenue was up 6.4% compared to the same quarter last year. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.
HCA Healthcare Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on HCA shares. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Bank of America downgraded HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a research report on Wednesday, July 16th. Truist Financial increased their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. Guggenheim assumed coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating on the stock. Finally, Barclays decreased their price target on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research note on Monday. Nine research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $396.46.
Read Our Latest Stock Report on HCA
Insider Buying and Selling at HCA Healthcare
In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.30% of the stock is owned by insiders.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report